Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Aging Pathobiology and Therapeutics is Scopus-indexed (Q2, CiteScore 1.6). Published by Ant Publishing Corporation.
Checked against the index lists dated .
ISSN 2690-1803Verify ISSN ↗
Publisher: Ant Publishing Corporation
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 29 / 57 | 50th | Q2 |
| Geriatrics and Gerontology | 94 / 123 | 23rd | Q4 |
| Drug Discovery | 136 / 161 | 15th | Q4 |
| Cellular and Molecular Neuroscience | 92 / 102 | 10th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q2, CiteScore 1.6.
Aging Pathobiology and Therapeutics is Q2 in Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (rank 29 of 57), Q4 in Geriatrics and Gerontology (rank 94 of 123) and Q4 in Drug Discovery (rank 136 of 161), by CiteScore 2025. It is ranked in 4 subject areas in all.
Aging Pathobiology and Therapeutics is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.6, quartile Q2, 50th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.308, quartile Q2, with an H-index of 10.
Aging Pathobiology and Therapeutics is published by Ant Publishing Corporation. Its ISSN is 2690-1803.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Aging Pathobiology and Therapeutics has an h-index of 12 and a 2-year mean of 0.77 citations per paper (OpenAlex). Its Scopus CiteScore is 1.6, quartile Q2. On 2-year citations it ranks #31 of 52 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (miscellaneous).
Aging Pathobiology and Therapeutics published 40 papers in 2025; its busiest recent year was 2020 with 48. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 80 research articles (2023–2026), authors are most often from United States (28.8%), India (19.4%) and China (10%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.